Overview of This Study:
This study involved four major activities in estimating the size of the organ preservation market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market.
The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the organ preservation solution market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and markets have been identified through extensive secondary research
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915
Key Questions Addressed by the Report:
# Which solution segment will dominate the organ preservation market in the future?
# Which technique segment will dominate the organ preservation market in the future?
# Emerging countries offer immense opportunities for the growth and adoption of organ preservation market; will this scenario continue in the coming five years?
# What are the upcoming products in the organ preservation market?
Static cold storage was the leading technique in 2019 but normothermic machine perfusion is expected to grow at a faster rate.
By technique, the segment witnessed a significant market share of Static cold storage in 2019. This technique is used for the preservation of the kidneys, liver, lung, pancreas, and heart. The low cost and requirements of SCS ensure its adoption among end-users. The advantages of normothermic machine perfusion provide its high growth rate in the solutions market in the forecast period of 2019 to 2024.
Geographical Growth Scenario:
“The Asia Pacific to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2019–2024. The major factors driving the growth of the Asia Pacific market include favorable government initiatives, increased awareness in people and increased organ donations. Intensified public education, mobilization, and advancements in organ transplant technologies have improved the donation rate in China.
In India, Rapid improvements in the country’s healthcare infrastructure have supported market growth while encouraging medical tourism. The willingness to donate organs in Japan has led to the improvement in organ donation despite religious issues. Other countries have initiative reimbursement programs, paired organ donation scheme with other patients within the country and across countries, have improved the growth of this market drastically.
Key Players:
XVIVO Perfusion AB (Sweden), Paragonix Technologies (US), Dr. Franz Kohler Chemie GMBH (Germany) are the leading players in the organ preservation market.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915
Expected Surge in Revenue:
The global organ preservation market is projected to reach USD 284 million by 2024 from USD 207 million in 2019, at a CAGR of 6.5%.
Industry Growth Influencing Factors:
The growth of the organ preservation market is mainly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, the high cost of organ transplantations and religious concerns in specific geographies are expected to limit market growth to a certain extent.
